Antioxidants | Selected Papers on Parkinson’s Disease Published in 2024–2025

We are pleased to highlight eight highly cited papers on Parkinson’s disease published in Antioxidants (ISSN: 2076-3921) in 2024 and 2025. These studies provide valuable insights into the role of oxidative stress in the pathogenesis of Parkinson’s disease, as well as antioxidant-related strategies for mitigating neurodegeneration.

1. “Exploring the Role of Reactive Oxygen Species in the Pathogenesis and Pathophysiology of Alzheimer’s and Parkinson’s Disease and the Efficacy of Antioxidant Treatment”
by Talin Gogna, Benjamin E. Housden and Annwyne Houldsworth
Antioxidants 2024, 13(9), 1138; https://doi.org/10.3390/antiox13091138
Full text available online: https://www.mdpi.com/2076-3921/13/9/1138

2. “Food and Food Waste Antioxidants: Could They Be a Potent Defence against Parkinson’s Disease?”
by Claudia Cannas, Giada Lostia, Pier Andrea Serra, Alessandra Tiziana Peana and Rossana Migheli
Antioxidants 2024, 13(6), 645; https://doi.org/10.3390/antiox13060645
Full text available online: https://www.mdpi.com/2076-3921/13/6/645

3. “Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson’s Disease”
by Sandro Huenchuguala and Juan Segura-Aguilar
Antioxidants 2024, 13(9), 1125; https://doi.org/10.3390/antiox13091125
Full text available online: https://www.mdpi.com/2076-3921/13/9/1125

4. “Sustained Systemic Antioxidative Effects of Intermittent Theta Burst Stimulation beyond Neurodegeneration: Implications in Therapy in 6-Hydroxydopamine Model of Parkinson’s Disease”
by Milica Zeljkovic Jovanovic, Jelena Stanojevic, Ivana Stevanovic, Milica Ninkovic, Nadezda Nedeljkovic and Milorad Dragic
Antioxidants 2024, 13(2), 218; https://doi.org/10.3390/antiox13020218
Full text available online: https://www.mdpi.com/2076-3921/13/2/218

5. “PET Imaging with [18F]ROStrace Detects Oxidative Stress and Predicts Parkinson’s Disease Progression in Mice”
by Yi Zhu, Neha Kohli, Anthony Young, Malkah Sheldon, Jani Coni, Meera Rajasekaran, Lozen Robinson, Rea Chroneos, Shaipreeah Riley, Joseph W. Guarnieri et al.
Antioxidants 2024, 13(10), 1226; https://doi.org/10.3390/antiox13101226
Full text available online: https://www.mdpi.com/2076-3921/13/10/1226

6. “A Single-Cell Atlas of the Substantia Nigra Reveals Therapeutic Effects of Icaritin in a Rat Model of Parkinson’s Disease”
by Hao Wu, Zhen-Hua Zhang, Ping Zhou, Xin Sui, Xi Liu, Yi Sun, Xin Zhao and Xiao-Ping Pu
Antioxidants 2024, 13(10), 1183; https://doi.org/10.3390/antiox13101183
Full text available online: https://www.mdpi.com/2076-3921/13/10/1183

7. “Evaluation of Additive Neuroprotective Effect of Combination Therapy for Parkinson’s Disease Using In Vitro Models”
by Alexander Shtilbans, Elise Esneault, Florian Simon, Joseph R. Mazzulli, Drew J. Quiriconi, Dror Rom, Wolfgang E. Reintsch, Andrea I. Krahn and Thomas M. Durcan
Antioxidants 2025, 14(4), 396; https://doi.org/10.3390/antiox14040396
Full text available online: https://www.mdpi.com/2076-3921/14/4/396

8. “Formulation and Physical–Chemical Analysis of Functional Muffin Made with Inulin, Moringa, and Cacao Adapted for Elderly People with Parkinson’s Disease”
by Paula García-Milla, Rocío Peñalver and Gema Nieto
Antioxidants 2024, 13(6), 683; https://doi.org/10.3390/antiox13060683
Full text available online: https://www.mdpi.com/2076-3921/13/6/683